By: The Sun Times
The Grey Bruce Health Unit reported six new cases of COVID-19 Wednesday.
The newest cases were found in Saugeen Shores, Brockton, Grey Highlands, Hanover and Southgate.
There are now 54 active COVID-19 cases confirmed by the health unit in the two counties including 37 involving a variant of concern. Two people with COVID-19 currently being followed by the health unit are hospitalized locally, according to Wednesday’s daily situation report.
The health unit is also following 160 active high-risk contacts of confirmed COVID-19 cases.
To date, 1,225 cases of COVID-19 have been confirmed by the health unit including 93 cases in health care workers. Of those, 1,166 cases are now considered resolved.
There were no ongoing COVID-19 outbreaks in Grey-Bruce as of Wednesday’s report.
The Grey Bruce Health Unit has now administered 62,486 doses of the COVID-19 vaccines including 5,287 in the past seven days.
On Monday, the National Advisory Council on Immunization (NACI) issued a recommendation for the Johnson & Johnson vaccine deeming it safe for people over 30 who don’t want to wait for an mRNA vaccine (Pfizer or Moderna).
NACI officials said a rare one-in-100,000 blood clotting risk associated with the two approved viral vector vaccines – Oxford AstraZeneca and Johnson & Johnson – is concern enough for some younger adults to weigh the risks of waiting for a mRNA vaccine option.
That risk assessment decision was specifically catered to those who live in non-urban settings or work at home and have a low risk of contracting COVID-19.
Dr. Ian Arra, Grey-Bruce’s medical officer of health, said the Grey Bruce Health Unit’s recommendation follows NACI’s, and that all of the vaccines approved for use in Canada have been deemed safe for those in the recommended groups, as per the scientific findings.
Health officials in New Brunswick reported Wednesday a resident in their 60s had died after developing blood clots following vaccination with the AstraZeneca vaccine.
The death is the third in Canada linked to the AstraZeneca vaccine, although public health officials across the country have said the risk of dying from COVID-19 far outweigh the risks of vaccine-induced blood clots for most Canadians.
Health Canada approved the Pfizer-BioNtech vaccine for children aged 12 to 15 Wednesday after a scientific review found it was safe and effective.
Research suggests children are less likely to get seriously ill with COVID-19, but they can still transmit the virus.
Clinical trials of the Pfizer-BioNTech vaccine among youth showed it had 100 per cent efficacy after two doses, officials said.
Canada is the first country in the world to authorize a vaccine for children.
Meanwhile, the province revealed the Moderna vaccine will be offered this week in up to 60 pharmacies spread throughout five health units, and expanded by the end of the week to 1,000 pharmacies provincewide.
Both announcements from the province come as Health Minister Christine Elliott said the province is now on track to administer the first doses of COVID-19 vaccines to 65 per cent of adults by the end of the month.
Public health units throughout Ontario reported 2,941 new COVID-19 cases Wednesday, the second day in a row fewer than 3,000 new cases were recorded.
Ontario also reported 44 new COVID-19 related deaths as well as 2,075 people in hospital including 882 people in intensive care units and 620 on a ventilator.
Over 132,000 doses of a COVID-19 vaccine were administered since Tuesday’s report, for a total of nearly 5.6 million doses.